Human Molecular Genetics, 2002, Vol. 11, No. 23 2951-2960
© 2002 Oxford University Press
Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice
1Department of Pediatrics, 2Department of Human Genetics and 3Division of Diabetes and Aging, Mount Sinai School of Medicine, New York, NY 10029, USA and 4LabCorp, Research Triangle Park, NC 27709, USA
Received July 25, 2002; Accepted September 3, 2002
Thiamin-responsive megaloblastic anemia syndrome (TRMA) is characterized by diabetes mellitus, megaloblastic anemia and sensorineural deafness. Mutations in the thiamin transporter gene SLC19A2 cause TRMA. To generate a mouse model of TRMA, we developed an Slc19a2 targeting construct using transposon-mediated mutagenesis and disrupted the gene through homologous recombination in embryonic stem cells. Erythrocytes from Slc19a2-/- mice lacked the high-affinity component of thiamin transport. On a thiamin-free diet, Slc19a2-/- mice developed diabetes mellitus with reduced insulin secretion and an enhanced response to insulin. The diabetes mellitus resolved after 6 weeks of thiamin repletion. Auditory-evoked brainstem response thresholds were markedly elevated in Slc19a2-/- mice on a thiamin-free diet, but were normal in wild-type mice treated on that diet as well as thiamin-fed Slc19a2-/- mice. Bone marrows from thiamin-deficient Slc19a2-/- mice were abnormal, with a megaloblastosis affecting the erythroid, myeloid and megakaryocyte lines. Thus, Slc19a2-/- mice have provided new insights into the TRMA disease pathogenesis and will provide a tool for studying the role of thiamin homeostasis in diabetes mellitus more broadly.
* To whom correspondence should be addressed at: Departments of Pediatrics and Human Genetics, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1498, New York, NY 10029, USA. Tel: +1 2126596705; Fax: +1 2128492508; Email: bruce.gelb{at}mssm.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. S Alzahrani, E. Baitei, M. Zou, and Y. Shi Thiamine transporter mutation: an example of monogenic diabetes mellitus Eur. J. Endocrinol., December 1, 2006; 155(6): 787 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shima, T. Maeda, S. Aizawa, I. Tsuboi, D. Kobayashi, R. Kato, and I. Tamai L-arginine import via cationic amino acid transporter CAT1 is essential for both differentiation and proliferation of erythrocytes Blood, February 15, 2006; 107(4): 1352 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Reidling and H. M. Said Adaptive regulation of intestinal thiamin uptake: molecular mechanism using wild-type and transgenic mice carrying hTHTR-1 and -2 promoters Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1127 - G1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. de Jong, Y. Meng, J. Dent, and S. Hekimi Thiamine Pyrophosphate Biosynthesis and Transport in the Nematode Caenorhabditis elegans Genetics, October 1, 2004; 168(2): 845 - 854. [Abstract] [Full Text] [PDF] |
||||



